PMSI supports Medmark in securing investment from Phoenix
Phoenix is pleased to announce its latest investment in Medmark, Ireland’s largest and most established occupational healthcare provider. The investment, which is subject to standard regulatory approvals, will support the company’s next phase of growth and innovation.
Founded in 1987, Medmark supports more than half a million employees through a range of occupational health, health screening, workplace medical assessment and employee wellbeing services. Operating from nine locations across the island of Ireland, the company is the market leader in Ireland in occupational health, serving public and private sector organisations of all sizes and helping employers to create safer and healthier workplaces.
This deal builds on Phoenix’s decades of experience in the healthcare space, joining investments such as Envisage and London Gynaecology.
Phoenix’s partnership with Medmark will help the organisation accelerate strategic initiatives already underway. This includes expanding its clinical and operational teams, investing further in technology and digital health platforms, enhancing customer reporting and service delivery, and broadening its geographic reach. The investment will also support Medmark in pursuing complementary acquisition opportunities and developing new services to meet the evolving occupational health and workplace wellbeing needs of employers across Ireland.
Dr Robert Ryan and Paul O’Grady will continue to lead Medmark’s day-to-day operations and strategic direction, with Phoenix supporting the business through board-level involvement, capital investment and access to operational expertise to help accelerate growth and development initiatives
PMSI provided VCDD to support the transaction. Our work addressed Medmark’s positioning and competitive standing in the Irish occupational health market, alongside assessment of the size, growth and demand drivers of that market. PMSI also assessed management’s growth plan and conducted a customer referencing programme.
On the support PMSI provided throughout the transaction, Deputy CEO Paul O’Grady commented “Gareth and the team at PMSI completed a comprehensive commercial due diligence exercise for Medmark. We found the team great to work with and it was clear from the outset that they had a comprehensive understanding of the occupational health market. Their report provided excellent insights which have been valuable to Medmark over and above the due diligence requirement.”
Read more